Medicare Enrolled
Dr. Todd Young, DO
Urology Physician · Fort Worth, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Young from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Young? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Young
Dr. Todd Young is an urology physician in Fort Worth, TX, with 20 years in practice. Based on federal Medicare data, Dr. Young performed 41,251 Medicare services across 6,260 unique beneficiaries.
Between the years covered by Open Payments, Dr. Young received a total of $22,025 from 73 pharmaceutical and/or device companies across 571 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Young is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 2% volume in TX$ $22,025 industry payments
Medicare Practice Summary
Medicare Utilization ↗41,251
Medicare services
Top 2% in TX for urology physician
6,260
Unique beneficiaries
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,063 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection | 13,422 | $0 | $0 |
| Infectious disease DNA/RNA test | 10,348 | $34 | $88 |
| Yeast/candida DNA test | 3,976 | $34 | $88 |
| Leuprolide injectable, camcevi, 1 mg | 2,394 | $67 | $239 |
| Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | 2,388 | $69 | $175 |
| Automated urinalysis | 1,240 | $2 | $16 |
| Office visit, established patient (30-39 min) | 1,123 | $87 | $319 |
| Bladder ultrasound after voiding | 971 | $8 | $27 |
| Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 795 | $34 | $88 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 795 | $34 | $88 |
| Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 795 | $34 | $88 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 795 | $34 | $88 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 795 | $34 | $88 |
| Drug injection, under skin or into muscle | 247 | $10 | $35 |
| Office visit, established patient (20-29 min) | 190 | $61 | $225 |
| Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | 109 | $611 | $1,977 |
| Chronic care management, first 20 min/month | 107 | $40 | $156 |
| Ceftriaxone antibiotic injection | 83 | $0 | $1 |
| New patient office visit (45-59 min) | 76 | $112 | $415 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 70 | $17 | $58 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 62 | $24 | $85 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 55 | $691 | $2,198 |
| Ultrasound scan of pelvic region through rectum | 52 | $102 | $508 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 42 | $299 | $973 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 41 | $25 | $160 |
| Insertion of device into abdomen with pressure and urine flow rate study | 41 | $153 | $486 |
| Office visit, established patient (10-19 min) | 40 | $36 | $141 |
| Electronic assessment of bladder emptying | 29 | $6 | $35 |
| Injection, garamycin, gentamicin, up to 80 mg | 28 | $2 | $7 |
| Destruction of tissue of bladder, urethra, or surrounding glands using an endoscope | 27 | $459 | $1,894 |
| Limited ultrasound scan behind abdominal cavity | 26 | $46 | $149 |
| Biopsy of prostate gland | 17 | $183 | $602 |
| Ultrasonic guidance for needle placement | 17 | $44 | $146 |
| Diagnostic exam of bladder and urethra using an endoscope | 16 | $165 | $604 |
| Shock wave crushing of kidney stones | 14 | $423 | $1,411 |
| New patient office visit (30-44 min) | 14 | $69 | $279 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 11 | $991 | $3,211 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$22,025
Total received (2018-2024)
Avg $3,146/year across 7 years
Top 11% in TX for urology physician
73
Companies
571
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,617 (93.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,249 (5.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$159 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,245
2023$1,544
2022$3,196
2021$2,028
2020$1,110
2019$5,235
2018$5,668
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Coloplast Corp
$7,087
Medtronic, Inc.
$2,246
PROCEPT BioRobotics Corporation
$1,575
Medtronic USA, Inc.
$1,467
COLOPLAST CORP
$695
Dendreon Pharmaceuticals LLC
$580
NeoTract Inc.
$562
Teleflex LLC
$547
Janssen Biotech, Inc.
$523
Boston Scientific Corporation
$488
Axonics, Inc.
$436
BOSTON SCIENTIFIC CORPORATION
$429
Astellas Pharma US Inc
$377
PFIZER INC.
$346
Olympus America Inc.
$240
Sumitomo Pharma America, Inc.
$237
AngioDynamics, Inc.
$230
Innovation Technologies Inc
$221
ABBVIE INC.
$217
Myovant Sciences Inc.
$211
Endo Pharmaceuticals Inc.
$209
UROVANT SCIENCES INC
$162
Verity Pharmaceuticals Inc.
$158
Antares Pharma, Inc.
$157
AbbVie Inc.
$149
Smith+Nephew, Inc.
$147
ACCORD HEALTHCARE, INC.
$134
Johnson & Johnson Health Care Systems Inc.
$129
Blue Earth Diagnostics Limited
$123
180 Medical, Inc.
$120
Laborie Medical Technologies Corp.
$119
C. R. Bard, Inc. & Subsidiaries
$92
Bayer HealthCare Pharmaceuticals Inc.
$91
Myriad Genetic Laboratories, Inc.
$89
HealthTronics Mobile Solutions, LLC
$87
Clarus Therapeutics Inc.
$81
Agiliti Surgical, Inc.
$71
AbbVie, Inc.
$64
Endo USA, Inc.
$60
Travere Therapeutics, Inc.
$59
Axonics Modulation Technologies, Inc.
$53
Tolmar, Inc.
$50
UROGEN PHARMA, INC.
$49
Progenics Pharmaceuticals, Inc.
$47
Acerus Pharmaceuticals Corporation
$45
Merck Sharp & Dohme LLC
$43
BioTissue Holdings, Inc.
$41
Baxter Healthcare
$39
Allergan, Inc.
$39
UroGen Pharma, Inc.
$39
Retrophin, Inc.
$37
TOLMAR Pharmaceuticals, Inc.
$37
Accord Healthcare, Inc.
$35
BIOTISSUE HOLDINGS, INC.
$32
Duchesnay USA Incorporated
$32
ConvaTec Inc.
$28
Mission Pharmacal Company
$28
BLUEWIND MEDICAL
$27
Avadel Specialty Pharmaceuticals, LLC
$26
Eisai Inc.
$25
Metuchen Pharmaceuticals
$25
Kerecis Limited
$25
Ferring Pharmaceuticals Inc.
$24
Caldera Medical, Inc
$24
Supernus Pharmaceuticals, Inc.
$22
Bayer Healthcare Pharmaceuticals Inc.
$21
GENZYME CORPORATION
$20
Hollister Incorporated
$19
MEDIVATION FIELD SOLUTIONS LLC
$16
Kowa Pharmaceuticals America, Inc.
$16
Ethicon US, LLC
$15
TherapeuticsMD, Inc.
$14
Augmenix, Inc.
$13
Top 3 companies account for 49.5% of total payments
Associated products mentioned in payments ›
(815) Thiola · 4-K · ADSTILADRIN · ADVANCE · ADVANTAGE · AMS · AQUABEAM SYSTEM · AVEED · Advantage System · Altis · Androgel · AquaBeam Robotic System · Axonics · Axonics r-SNM System · Axumin · BOTOX · Bulkamid · CAMCEVI · Desara · Dormia · ECHELON FLEX Stapler · ELIGARD · ENDOUROLOGY · ERLEADA · Endocare Cryocare System · Erleada · GEMTESA · GENERAL BPH · GENERAL ERECTILE DYSFUNCTION · GENERAL FEMALE SUI · GENERAL KIDNEY STONE DISEASE · GENERAL - BPH · GENERAL - ERECTILE DYSFUNCTION · GENERAL - THERAPIES · GENERAL ERECTILE DYSFUNCTION · GENERAL FEMALE SUI · GENERAL THERAPIES · GENTLECATH · GREENLIGHT · General - Therapies · IMVEXXY · INLAY · INTERSTIM · INTEllIO LINK WEREWOLF · IRRISEPT · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · Kerecis Omega3 SurgiClose · LUPRON DEPOT · Lenvima · LithoVue · Lupron · Lupron Depot · MYRBETRIQ · Mobile Cryoblation Services · Myrbetriq · NANOKNIFE · NEOX · Natesto · Noctiva · Nubeqa · ONLI · ORGOVYX · OTREXUP · Onli · Optilume BPH Drug Coated Balloon Catheter · Osphena · PENILE & TESTICULAR RECONSTRUCTN · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · Prolaris · REZUM · Rezum Generator · SEGLENTIS · SOLYX · STELARA · SUTENT · SpaceOAR · Stendra · TESTOPEL · TISSEEL · TITAN · Thiola · Titan · Trelstar · UROLIFT · Uribel · UroLift · UroLift System · Veozah · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $53 per 100 Medicare services performed
Geographic Context
Urology Physicians within 10 mi
85
Per 100K population
4.0
County median income
$81,905
Nearest hospital
TEXAS HEALTH HARRIS METHODIST HOSPITAL SOUTHWEST F
2.8 mi
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Young is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 11%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Young experienced with testosterone injection?
Based on Medicare claims data, Dr. Young performed 13,422 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Young receive payments from pharmaceutical companies?
Yes. Dr. Young received a total of $22,025 from 73 companies across 571 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Young's costs compare to other urology physicians in Fort Worth?
Dr. Young's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Young) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Fort Worth
Browse urology physicians in Fort Worth ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology